Kuros Biosciences AG Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Kuros Biosciences AG stock has a consensus rating of "Buy" and an average price target of CHF 35.40. The average 1-year stock price forecast is 98.99% higher than the current stock price, while the lowest is CHF 32.80 (+84.37%) and the highest is CHF 38.00 (+113.60%).

Price Target: CHF 35.40 (+98.99%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	CHF 32.80	CHF 35.40	CHF 35.40	CHF 38.00
Change	+84.37%	+98.99%	+98.99%	+113.60%

* Price targets were last updated on Apr 14, 2026.

Analyst Ratings

The average analyst rating for Kuros Biosciences AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Jan '26	Feb '26	Mar '26	May '26	Jun '26
Strong Buy	0	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christophe dombu Kepler Capital	Kepler Capital	Buy Maintains CHF 38.00	Buy	Maintains	CHF 38.00	+113.60%	Apr 14, 2026

Financial Forecast

Revenue This Year

202.05M

from 146.06M

38.34%

from 146.06M

Revenue Next Year

287.69M

from 202.05M

42.39%

from 202.05M

EPS This Year

0.19

from 0.06

222.10%

from 0.06

EPS Next Year

0.56

from 0.19

190.00%

from 0.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	15.15M	19.45M	39.86M	85.16M	146.06M	202.05M
Revenue Growth	231.96%	28.35%	104.92%	113.65%	71.51%	38.34%
Gross Profit	11.04M	15.54M	33.81M	75.67M	127.45M	180.63M
Gross Margin	72.86%	79.89%	84.83%	88.85%	87.26%	89.40%
Operating Income	-9.62M	-10.65M	-6.04M	120.00K	8.95M	18.33M
Net Income	-8.27M	-15.78M	-16.30M	-4.84M	2.55M	12.75M
EPS	-	-	-	-	0.06	0.19
EPS Growth	-	-	-	-	-	222.10%
Forward PE	-	-	-	-	-	114.21
Free Cash Flow	5.75M	-4.84M	-10.15M	4.63M	-3.93M	30.55M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	202.1M
Avg	202.1M
Low	202.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	38.3%
Avg	38.3%
Low	38.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.19
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	222.1%
Low	-